WellSpan Health Announces plans to Scale Clinical AI Across its Hospital Network

The initiative aims to scale Aidoc’s clinical AI Operating System (aiOS) across all nine of its hospitals and more than 250 care locations.

WellSpan Health, a leading Pennsylvania-based healthcare system, has announced plans to expand the use of clinical artificial intelligence (AI) technology across its entire network.

The initiative aims to scale Aidoc’s clinical AI Operating System (aiOS) across all nine of its hospitals and more than 250 care locations.

In parallel, WellSpan will also activate 21 additional AI-powered care pathways across seven service lines, which is expected to enhance clinical decision support in more specialties beyond radiology.

The initiative follows the initial deployment of the AI platform, which demonstrated measurable value in identifying critical findings and accelerating time-sensitive diagnoses.

In the past year, Aidoc analyzed more than 200,000 patient cases across WellSpan, flagging over 10,000 potentially critical findings, including pulmonary emboli, brain hemorrhages, and vessel occlusions.

This expansion has reportedly reduced bottlenecks in urgent diagnostic workflows and unlocked measurable improvements in turnaround time by accelerating standardized, high-quality care across the network.

Commenting on the new initiative, Roxanna Gapstur, President and CEO of WellSpan, said, “Aidoc has augmented our radiologists’ expertise for higher quality and safety, greater accuracy, and a better work experience, especially important amid today’s physician shortage. Now, with this expansion, patients across the entire WellSpan system will be able to benefit, experiencing faster, more accurate diagnoses and improved health outcomes.”

As per the new expansion strategy, the aiOS platform will be fully integrated with WellSpan’s electronic medical record (EMR) and imaging environments, which seek to support seamless workflows that connect multiple departments and care teams.

The new solutions are designed to broaden clinical coverage, supporting care teams in flagging conditions such as aortic dissection, free air in the abdomen and pelvis, pneumothorax, rib fractures, and more while expanding AI support across service lines, including cardiology, vascular surgery, and neuroscience.

Further, the rollout integrates third-party clinical AI tools within the aiOS platform to support the detection of lung nodules and breast lesions.

By scaling Aidoc’s aiOS across specialties, WellSpan aims to integrate a unified intelligence layer into everyday workflows that is expected to enhance care efficiency, physician satisfaction, and reduce burnout.

These capabilities support automated routing of patients with flagged findings to the appropriate care teams, which is expected to streamline care coordination, ensure timely intervention, and support long-term patient outcomes.

Reflecting his thoughts on the new partnership, Elad Walach, co-founder and CEO of Aidoc, said, “ WellSpan has mastered the motion of change management and clinical AI adoption. By scaling Aidoc aiOS across specialties, WellSpan is embedding a unified intelligence layer into everyday workflows that elevates efficiency of care while improving physician satisfaction and reducing burnout. This is how health systems elevate clinical operations at scale.”

Stay tuned for more such updates on Digital Health News